BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 15233214)

  • 1. Rationale of pre-surgical medical treatment with somatostatin analogs in acromegaly.
    Cappabianca P; Cavallo LM; Esposito F; Romano I; Colao A; de Divitiis E
    J Endocrinol Invest; 2003; 26(8 Suppl):55-8. PubMed ID: 15233214
    [No Abstract]   [Full Text] [Related]  

  • 2. The effects of somatostatin analogs on tumor shrinkage in acromegaly.
    Pedroncelli AM; Montini M; Albizzi M; Barbò R; Pagani G
    J Endocrinol Invest; 2003; 26(8 Suppl):50-4. PubMed ID: 15233213
    [No Abstract]   [Full Text] [Related]  

  • 3. The effects of somatostatin analogs on biochemical parameters in acromegaly.
    Liuzzi A; Marzullo P
    J Endocrinol Invest; 2003; 26(8 Suppl):46-9. PubMed ID: 15233212
    [No Abstract]   [Full Text] [Related]  

  • 4. The treatment algorithm of acromegaly.
    Colao A; Pivonello R; Cappabianca P; Vitale G; Lombardi G
    J Endocrinol Invest; 2003; 26(8 Suppl):39-45. PubMed ID: 15233211
    [No Abstract]   [Full Text] [Related]  

  • 5. Conclusions: the future role of somatostatin analogs.
    Lamberts SW
    J Endocrinol Invest; 2003; 26(8 Suppl):134-5. PubMed ID: 15233230
    [No Abstract]   [Full Text] [Related]  

  • 6. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.
    Tolis G; Angelopoulos NG; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Protonotariou A; Lytras A
    Neuroendocrinology; 2006; 83(3-4):249-57. PubMed ID: 17047390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transsphenoidal microsurgery for newly diagnosed acromegaly: a personal view after more than 1,000 operations.
    Ludecke DK; Abe T
    Neuroendocrinology; 2006; 83(3-4):230-9. PubMed ID: 17047388
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multimodality treatment of pituitary adenomas.
    Oyesiku NM
    Clin Neurosurg; 2005; 52():234-42. PubMed ID: 16626076
    [No Abstract]   [Full Text] [Related]  

  • 9. Presurgical octreotide treatment in acromegaly: no improvement of final growth hormone (GH) concentration and pituitary function. A long-term case-control study.
    Plöckinger U; Quabbe HJ
    Acta Neurochir (Wien); 2005 May; 147(5):485-93; discussion 493. PubMed ID: 15806331
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide.
    Lamberts SW; van der Lely AJ; de Herder WW; Hofland LJ
    N Engl J Med; 1996 Jan; 334(4):246-54. PubMed ID: 8532003
    [No Abstract]   [Full Text] [Related]  

  • 11. In vitro testing of new somatostatin analogs on pituitary tumor cells.
    Zatelli MC; Ambrosio MR; Bondanelli M; degli Uberti EC
    Mol Cell Endocrinol; 2008 May; 286(1-2):187-91. PubMed ID: 18243520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogues.
    Wass J
    Eur J Endocrinol; 2005 May; 152(5):693-4. PubMed ID: 15879353
    [No Abstract]   [Full Text] [Related]  

  • 13. Distribution and functionality of the somatostatin receptor subtypes in acromegaly.
    Saveanu A; Gunz G; Dufour H; Enjalbert A; Culler MD; Jaquet P
    J Endocrinol Invest; 2003; 26(8 Suppl):4-7. PubMed ID: 15233203
    [No Abstract]   [Full Text] [Related]  

  • 14. Somatostatin analogs in acromegaly.
    Freda PU
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3013-8. PubMed ID: 12107192
    [No Abstract]   [Full Text] [Related]  

  • 15. Prolonged preoperative treatment of acromegaly with Somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1-3): a retrospective cohort study conducted at a single center.
    Duan L; Zhu H; Xing B; Gu F
    BMC Endocr Disord; 2017 Sep; 17(1):55. PubMed ID: 28874187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal Insulin-like Growth Factor 1 During Somatostatin Receptor Ligand Treatment Predicts Surgical Cure in Acromegaly.
    Losa M; Garbin E; Pedone E; Mortini P
    J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32609842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The quality of life in acromegaly.
    Pantanetti P; Sonino N; Arnaldi G; Boscaro M
    J Endocrinol Invest; 2003; 26(8 Suppl):35-8. PubMed ID: 15233210
    [No Abstract]   [Full Text] [Related]  

  • 18. Does octreotide treatment improve the surgical results of macro-adenomas in acromegaly? A randomized study.
    Kristof RA; Stoffel-Wagner B; Klingmüller D; Schramm J
    Acta Neurochir (Wien); 1999; 141(4):399-405. PubMed ID: 10352750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new treatment for an old disease.
    Daughaday WH
    N Engl J Med; 1985 Dec; 313(25):1604-5. PubMed ID: 2866446
    [No Abstract]   [Full Text] [Related]  

  • 20. Pregnancy in persistent acromegaly.
    Hierl T; Ziegler R; Kasperk C
    Clin Endocrinol (Oxf); 2000 Aug; 53(2):262-3. PubMed ID: 10931109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.